Drug

Sublocade clinical trials

studies test it: 16
open now: 2
in phase 3: 4
first study started: 2019

Keep track of what changes. Save the Sublocade studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Sublocade: 12
Extended Release Buprenorphine: 5

Combined with it in one product

Combined LAI Treatment: Cabenuva and Sublocade: 1
rilpivirine (CAB/RPV) "cabenuva": 1
extended-release buprenorphine (XR-B) "sublocade": 1

Studies by the year they started

16 studies that test it; most in 2019 (4)

Studies that test Sublocade, by start year
Year	Studies
2019	4
2020	1
2021	2
2022	3
2023	2
2024	1
2025	2
2026	1

By phase

A phase 1/2 study counts in both.

Phase 1: 1
Phase 2: 7
Phase 3: 4
Phase 4: 6

What it is tested for

Each study’s main condition, where its own words name it.

Opioid-Related Disorders: 12
Opiate Overdose: 1

Who runs them

Industry 3 · Other 13

Indivior Inc. (3) · NYU Langone Health (2) · Virginia Commonwealth University (2) · Friends Research Institute, Inc. (1) · Frances R Levin (1) · Gavin Bart (1) · University of Texas Southwestern Medical Center (1) · New York State Psychiatric Institute (1)

Often tested with

Tested in the same studies.

INDV-6001 (1) · Naltrexone (1) · Buprenorphine (1) · Cabotegravir, rilpivirine drug combination (1)

Studies

Open first, then newest update. How each study uses Sublocade is read from its arms, and is right about nine times in ten.